Cellular Engineering Technologies
Biotechnology, 2500 Crosspark Rd, Coralville, Iowa, 52241, United States, 1-10 Employees
Phone Number: +15*********
Who is CELLULAR ENGINEERING TECHNOLOGIES
Cellular Engineering Technologies, Inc. (CET) provides optimized reagents and human cell lines that address the technical and clinical challenges of developing next-generation cell therap...
Read More
-
Headquarters: 2500 Crosspark Rd, Coralville, Iowa, 52241, United States
-
Date Founded: 2000
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8711
|
NAICS Code: 541330 |
Show More
Does something look wrong? Fix it. | View contact records from CELLULAR ENGINEERING TECHNOLOGIES
Cellular Engineering Technologies Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Cellular Engineering Technologies
Answer: Cellular Engineering Technologies's headquarters are located at 2500 Crosspark Rd, Coralville, Iowa, 52241, United States
Answer: Cellular Engineering Technologies's phone number is +15*********
Answer: Cellular Engineering Technologies's official website is https://celleng-tech.com/index/aboutcet.html
Answer: Cellular Engineering Technologies's revenue is $1 Million to $5 Million
Answer: Cellular Engineering Technologies's SIC: 8711
Answer: Cellular Engineering Technologies's NAICS: 541330
Answer: Cellular Engineering Technologies has 1-10 employees
Answer: Cellular Engineering Technologies is in Biotechnology
Answer: Cellular Engineering Technologies contact info: Phone number: +15********* Website: https://celleng-tech.com/index/aboutcet.html
Answer: Cellular Engineering Technologies, Inc. (CET) provides optimized reagents and human cell lines that address the technical and clinical challenges of developing next-generation cell therapies and regenerative medicines. We offer native, human recombinant growth factors and cytokines that are designed to generate maximum cellular response and bioavailability. Our portfolio of human somatic stem cells and induced pluripotent stem cells, programmed using our patented virus and oncogene-free methods, produce the safest and most scalable starting cell line for your research and manufacturing needs. We also leverage our human protein expression models to create custom protein and peptide sequences. Contact one of our application scientists today to discuss how our bioproduction and cell line engineering expertise can accelerate your drug discovery or IND-enabling activities.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month